Biodefense Market Size By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays And Reagents}), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Jan 2019  |  Report ID: GMI714  |  Authors: Sumant Ugalmugle

Report Format: PDF   |   Pages: 115   |   Base Year: 2017

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Biodefense Market size was valued at USD 12.2 billion in 2017 and is expected to witness 6.8% CAGR from 2018 to 2024.

Biodefense Market

Get more details on this report - Request Free Sample PDF

Growing awareness regarding bioterrorism attacks in developed countries such as the U.S. and Germany will significantly boost the market growth over forthcoming years. Bioterrorism attacks are intentional release of bacteria, viruses and other harmful microbes that are capable of spreading epidemics leading to deaths. This situation adversely impacts the economy as it affects the human health and leads to depletion of human resource. Hence, government in developed countries undertakes several initiatives as well as preventive measures to survive these attacks. Government usually stocks vaccines and biothreat detection devices to ensure maximum security of the population. Such government initiatives will boost the market growth.

Increasing technological advancements will have positive impact on the industry growth during the analysis period. Due to growing bioterrorism activities, key industry players have added innovations in the biothreat detection devices that help in efficient of bacteria and viruses. Availability of technologically advanced biothreat detection devices will ensure safety and security of the population that will augment the industry growth. However, low R&D funding for manufacturing vaccines against bioterrorism attacks by government in developing and underdeveloped countries will hamper the market growth up to some extent.

Biodefense Market Report Coverage
Report Coverage Details
Base Year: 2017 Market Size in 2017: 12.2 Billion (USD)
Historical Data for: 2013 to 2017 Forecast Period: 2018 to 2024
Forecast Period 2018 to 2024 CAGR: 6.8% 2024 Value Projection: 19 Billion (USD)
Pages: 115 Tables, Charts & Figures: 50
Geographies covered (17): U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE
Segments covered: Product and Region
Companies covered (16): Achaogen, Alnylam Pharmaceuticals, Altimmune, Alexeter Technologies, LLC, ANP Technologies, Bavarian Nordic, BBI Detection, Cleveland BioLabs, Inc., DynPort Vaccine Company LLC, Elusys Therapeutics, Emergent BioSolutions, Ichor Medical Systems, Inc., New Horizons Diagnostics, PathSensors, Research International, SIGA Technologies
Growth Drivers:
  • Growing investments by government in R&D in North America & Europe
  • Favorable government initiatives in Asia Pacific and Latin America
  • Technological advancements in biotechnology sector in North America and Europe
Pitfalls & Challenges:
  • Low R&D funding by government in underdeveloped regions

Request 15% Free Customization on this Report

Biodefense Market, By Product

Vaccines segment was valued at USD 7.8 billion in 2017 and significant revenue size can be associated with increasing expenditures in R&D by pharmaceutical and biopharmaceutical companies. Currently, researchers are exploring new vaccine technologies that includes vector technology to induce rapid protection against pathogen attack. Recently developed vaccines have flexibility to address various bioterrorism agents and possess ability to generate a long-lasting immune response after a single oral dose. Development of such efficient vaccines will foster segmental growth.

Bio-threat detection devices segment will experience 6.6% CAGR during the forecast timeframe. Key industry players operational in biodefense industry have developed portable detectors. Furthermore, Defense Advanced Research Project Agency (DARPA) has provided funding for a portable bio-threat detection device that is capable of analyzing DNA from a sample to efficiently detect the presence of infectious, bacterial or fungal agent within a short time span. Growing adoption of rapid biothreat detection systems will trigger segment growth.

Germany Biodefense Market By Vaccines

Get more details on this report - Request Free Sample PDF

Biodefense Market, By Region

U.S. market will experience 6.5% CAGR throughout the forecast period and is expected to grow substantially. U.S. government implements several initiatives that helps them in strengthening security against bioterrorism attacks. Government plans several biodefense programs such as pandemic influenza and infectious disease program. Also, government initiates several programs focused on preparedness and prevention intentional or accidental releases of biological material will stimulate the U.S. biodefense market in forthcoming years.

Japan market was valued at USD 931.8 million in 2017. High awareness regarding availability of technologically advanced biothreat detection devices will surge the industry growth during the analysis timeframe. Furthermore, rising government initiatives and funding to prevent bioterrorism in Japan will positively influence the industry growth in foreseeable future.

Asia Pacific Biodefense Market By Country

Get more details on this report - Request Free Sample PDF

Competitive Market Share

Eminent industry players operational in biodefense market includes Altimmune, Emergent BioSolutions, SIGA Technologies, Elusys Therapeutics, Ichor Medical Systems, DynPort Vaccine Company, Cleveland BioLabs, Bavarian Nordic, Achaogen, Alnylam Pharmaceuticals, PathSensors and BBI Detection. These key industry players implement strategic initiatives such as geographic expansions, new product launch and acquisitions to gain prominent market share. For instance, in January 2017, Altimmune and PharmAthenemer underwent merger to introduce next generation anthrax vaccine utilized in biodefense. This merger will prove beneficial for the growth of both the companies.

Biodefense Industry Background

Biodefense industry still in the development stage. Government in developed as well as developing countries undertakes various initiatives that ensures security of the population. The government plans programs that involves stocking of vaccines and biodefense machines utilized in case of sudden bioterrorism attack. For instance, Project Bioshield Act was signed in July 2004 to invest in procurement of vaccines and biothreat detection diseases. Biodefense industry will experience lucrative growth opportunities if the government takes frequent preventive measures to assure safety of population and the economy.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

GMIPulse Subscription

An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.

Start Your Free Trial
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X